SAN CARLOS, Calif., April 6, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing and non-invasive prenatal testing (NIPT) today announced an ...
SAN CARLOS, Calif., Oct. 2, 2017 /PRNewswire/ -- Natera (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that the company's ...
SAN CARLOS, Calif. & DALLAS--(BUSINESS WIRE)--Natera, a leading innovator in prenatal genetic testing, today announced the initiation of a distribution partnership with ProPath, a wholly ...
Natera, Inc. a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced the publication of a large clinical experience study evaluating the performance of ...
Natera announced Tuesday that it was ending the Panorama distribution agreement Natera said, under the agreement, BioReference was not to disparage the Natera test BioReference’s brochures promoting a ...
Natera, a leading innovator in prenatal genetic testing, announced today that data demonstrating the accuracy of its non-invasive prenatal screening test, Panorama™, in detection of multiple sex ...
Natera (San Carlos, California) has completed a $54.6 million financing round to support the expansion and continued global rollout of its non-invasive prenatal test, Panorama. The test uses fetal ...
TAMPA (FOX 13) - Every mother wants their newborn to be healthy, but not every pregnancy is risk-free. There is a new prenatal test helping to find abnormalities as early as nine weeks into pregnancy.
Natera, a provider of prenatal genetic testing, announced that its non-invasive prenatal test (NIPT), Panorama, will now be available to expecting parents in California at no cost as part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback